Nektar Therapeutics (NKTR)
NASDAQ: NKTR · Real-Time Price · USD
76.43
+0.93 (1.23%)
Aug 12, 2026, 10:04 AM EDT - Market open
Nektar Therapeutics Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 55.63 | 55.23 | 98.43 | 90.12 | 92.06 | 101.91 |
Revenue Growth | -36.24% | -43.89% | 9.21% | -2.10% | -9.67% | -33.36% |
Gross Profit Gross Profit Growth | 55.63 | 55.23 | 67.74 | 56.35 | 70.42 | 77.01 |
Operating Income Operating Income Growth | -134.62 | -140.1 | -105.2 | -263.68 | -376.17 | -446.1 |
Net Income Net Income Growth | -158.1 | -164.08 | -118.96 | -276.06 | -368.2 | -523.84 |
Earnings Per Share EPS Growth | -8.42 | -9.73 | -8.68 | -21.75 | -29.55 | -42.90 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
United States United States Growth | - | 1.38 | 11.48 | 9.84 | 10.11 |
Rest of World Rest of World Growth | 55.23 | 97.05 | 78.64 | 82.21 | 91.79 |
Total Total Growth | 55.23 | 98.43 | 90.12 | 92.06 | 101.91 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 568.6 | 245.75 | 255.23 | 303.62 | 504.98 | 733.96 |
Total Debt Total Debt Growth | 83.16 | 85.75 | 102.56 | 117.78 | 131.5 | 143.18 |
Net Cash (Debt) Net Cash Growth | 485.44 | 160 | 152.66 | 185.84 | 373.48 | 590.78 |
Net Cash Growth | 310.37% | 4.81% | -17.85% | -50.24% | -36.78% | -35.19% |
Net Cash Per Share Net Cash Per Share Growth | 24.87 | 9.48 | 11.13 | 14.67 | 29.94 | 48.35 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -203.76 | -208.51 | -175.71 | -192.61 | -304.01 | -412.66 |
Capital Expenditures CapEx Growth | -0.19 | -0.17 | -1.47 | -0.87 | -5.68 | -14.99 |
Free Cash Flow Free Cash Flow Growth | -203.94 | -208.68 | -177.18 | -193.47 | -309.68 | -427.65 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 100.00% | 100.00% | 68.82% | 62.53% | 76.50% | 75.57% |
Operating Margin | -241.98% | -253.66% | -106.88% | -292.59% | -408.63% | -437.76% |
Pretax Margin | -273.59% | -281.52% | -121.10% | -306.54% | -396.48% | -513.49% |
Profit Margin | -273.37% | -281.27% | -120.86% | -306.31% | -399.98% | -514.03% |
FCF Margin | -366.59% | -377.83% | -180.01% | -214.68% | -336.41% | -419.65% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Forward PE | - | 15.88 | 15.88 | 15.88 | 15.88 | 15.88 |
PS Ratio | 45.85 | 15.60 | 1.76 | 1.20 | 4.63 | 24.59 |